Liver fibrosis staging

Liver fibrosis staging assesses the degree of scarring in the liver, ranging from no scarring to cirrhosis (the most advanced stage), helping guide prognosis and treatment decisions. It's an important part of managing chronic liver conditions.

Liver fibrosis develops as a response to ongoing liver injury from causes such as chronic viral hepatitis, long-term alcohol use, non-alcoholic fatty liver disease, or autoimmune liver conditions. The degree of fibrosis generally reflects how long and how severely the liver has been affected by the underlying cause.

Staging typically uses a scale from F0 (no fibrosis) to F4 (cirrhosis), assessed through non-invasive methods such as specialised elastography scans (like FibroScan), blood-based fibrosis scoring systems, or occasionally liver biopsy in specific cases. Non-invasive methods have largely replaced biopsy for routine staging.

The risk increases with the stage: early fibrosis often causes no symptoms and may be reversible if the cause is addressed, while advanced fibrosis and cirrhosis carry significant risk of complications including liver failure and liver cancer. Regular staging helps track progression and guide the urgency of intervention.

Yes, particularly at earlier stages, fibrosis can improve or even reverse if the underlying cause is successfully treated, such as achieving weight loss for fatty liver disease, curing viral hepatitis, or stopping alcohol use. This is a key reason why early diagnosis and staging matter.

Treatment focuses on managing the underlying cause of liver damage, since there's no direct treatment that removes existing scar tissue on its own. Addressing the cause effectively, alongside a generally healthy lifestyle, gives the fibrosis the best chance to stabilise or improve.

This depends on the underlying condition and current fibrosis stage, but is often repeated periodically, such as every one to three years, to monitor progression or improvement, more frequently in higher-risk situations. Your hepatologist will advise on an appropriate schedule for your specific situation.

FibroScan (elastography) is a non-invasive scan that estimates liver stiffness as a marker of fibrosis without needing a needle procedure, while liver biopsy directly samples liver tissue for detailed examination but is more invasive with a small associated risk. FibroScan has become the preferred first-line method for most routine fibrosis staging due to its simplicity and safety.

Advanced fibrosis or cirrhosis typically means closer monitoring for complications, including regular screening for liver cancer and assessment of internal vein enlargement, alongside more careful management of any procedures or medications that could stress the liver further. Your specialist will discuss what this means specifically for your ongoing care.

If you have a chronic liver condition or risk factors for liver disease, hepatology assessment including fibrosis staging is worthwhile. Private hepatology consultations can typically be arranged within about two weeks, considerably faster than standard NHS waiting times.